Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siteng Chen

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Cancer Research and Clinical Oncology|August 9, 2023
Development and verification of a deep learning-based m<sup>6</sup>A modification model for clinical prognosis prediction of renal cell carcinomaSiteng Chen, Encheng Zhang, Tuanjie Guo, et al.
Cancer Management and Research|December 17, 2021
miR-145-5p: A Potential Biomarker in Predicting Gleason Upgrading of Prostate Biopsy Samples Scored 3+3=6Tao Wang, Lei Dong, Juanjuan Sun, et al.
Frontiers in Immunology|February 24, 2022
Robust Prediction of Prognosis and Immunotherapeutic Response for Clear Cell Renal Cell Carcinoma Through Deep Learning AlgorithmSiteng Chen, Encheng Zhang, Liren Jiang, et al.
Frontiers in Oncology|July 5, 2021
A Novel Nomogram Based on Machine Learning-Pathomics Signature and Neutrophil to Lymphocyte Ratio for Survival Prediction of Bladder Cancer PatientsSiteng Chen, Liren Jiang, Encheng Zhang, et al.
Heliyon|June 5, 2023
Screening and identification of prognostic genes associated with eosinophilic features of clear cell renal cell carcinomaTuanjie Guo, Liren Jiang, Tao Wang, et al.
Journal of Cancer|January 2, 2020
The study on copy number alteration of clear cell renal cancer in Chinese populationNing Zhang, Siteng Chen, Guangliang Jiang, et al.
Heliyon|September 26, 2022
Machine learning-based prognosis signature for survival prediction of patients with clear cell renal cell carcinomaSiteng Chen, Tuanjie Guo, Encheng Zhang, et al.
Cancer Science|May 1, 2021
Clinical use of machine learning-based pathomics signature for diagnosis and survival prediction of bladder cancerSiteng Chen, Liren Jiang, Xinyi Zheng, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 16, 2023
Competition between p53 and YY1 determines PHGDH expression and malignancy in bladder cancerTiezhu Shi, Zhihao Yuan, Yanying He, et al.
Pathology|August 21, 2024
Deep learning-based diagnosis and survival prediction of patients with renal cell carcinoma from primary whole slide imagesSiteng Chen, Xiyue Wang, Jun Zhang, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Cancer Research and Clinical Oncology|August 9, 2023
Development and verification of a deep learning-based m<sup>6</sup>A modification model for clinical prognosis prediction of renal cell carcinomaSiteng Chen, Encheng Zhang, Tuanjie Guo, et al.
Cancer Management and Research|December 17, 2021
miR-145-5p: A Potential Biomarker in Predicting Gleason Upgrading of Prostate Biopsy Samples Scored 3+3=6Tao Wang, Lei Dong, Juanjuan Sun, et al.
Frontiers in Immunology|February 24, 2022
Robust Prediction of Prognosis and Immunotherapeutic Response for Clear Cell Renal Cell Carcinoma Through Deep Learning AlgorithmSiteng Chen, Encheng Zhang, Liren Jiang, et al.
Frontiers in Oncology|July 5, 2021
A Novel Nomogram Based on Machine Learning-Pathomics Signature and Neutrophil to Lymphocyte Ratio for Survival Prediction of Bladder Cancer PatientsSiteng Chen, Liren Jiang, Encheng Zhang, et al.
Heliyon|June 5, 2023
Screening and identification of prognostic genes associated with eosinophilic features of clear cell renal cell carcinomaTuanjie Guo, Liren Jiang, Tao Wang, et al.
Journal of Cancer|January 2, 2020
The study on copy number alteration of clear cell renal cancer in Chinese populationNing Zhang, Siteng Chen, Guangliang Jiang, et al.
Heliyon|September 26, 2022
Machine learning-based prognosis signature for survival prediction of patients with clear cell renal cell carcinomaSiteng Chen, Tuanjie Guo, Encheng Zhang, et al.
Cancer Science|May 1, 2021
Clinical use of machine learning-based pathomics signature for diagnosis and survival prediction of bladder cancerSiteng Chen, Liren Jiang, Xinyi Zheng, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 16, 2023
Competition between p53 and YY1 determines PHGDH expression and malignancy in bladder cancerTiezhu Shi, Zhihao Yuan, Yanying He, et al.
Pathology|August 21, 2024
Deep learning-based diagnosis and survival prediction of patients with renal cell carcinoma from primary whole slide imagesSiteng Chen, Xiyue Wang, Jun Zhang, et al.
Pageof 5